China NMPA Issues New Regulations on Designating Domestic Agents for Overseas Drug MAH Compliance
November 14, 2024 The National Medical Products Administration (NMPA) has officially released the Interim Provisions on the Management of Domestic Agents Designated by Overseas Marketing Authorization Holders (MAH) of Drugs, with new regulations effective from July 1, 2025. These measures are set to strengthen the oversight of overseas MAHs by mandating the appointment of a…